|
Pharmaceutical Companies |
Name |
FV |
CMP |
52week High |
52week Low |
Mkt Cap |
Equity Cap |
Networth |
Total Debt |
BV |
Net Sales |
PAT |
EPS |
P/E |
P/BV |
Promoter Holding |
|
(Rs.) |
(Rs.) |
(Rs.) |
(Rs.) |
(Rs.Crs) |
(Rs.Crs) |
(Rs.Crs) |
(Rs.Crs) |
(Rs.) |
(Rs.Crs) |
(Rs.Crs) |
(Rs.) |
|
|
% |
Indian |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sun Pharma |
1 |
421.55 |
678.8 |
350.4 |
101141 |
240 |
41409 |
9893 |
172.6 |
30091 |
2665 |
11.1 |
37.9 |
2.4 |
54.38 |
Dr. Reddys Labs |
5 |
2611.95 |
2965.2 |
2017.2 |
43373 |
83 |
14024 |
3413 |
844.8 |
15786 |
1950 |
117.5 |
22.2 |
3.1 |
26.77 |
Cipla |
2 |
537.9 |
678 |
483.75 |
43346 |
161 |
15012 |
4316 |
186.3 |
16839 |
1492 |
18.5 |
29.0 |
2.9 |
36.7 |
Divis Labs |
2 |
1630 |
1769 |
1068.1 |
43237 |
53 |
6957 |
106 |
262.1 |
5102 |
1353 |
51.0 |
32.0 |
6.2 |
52.01 |
Aurobindo Pharma |
1 |
569.25 |
838 |
546 |
33353 |
59 |
13891 |
6573 |
237.1 |
19679 |
2365 |
40.4 |
14.1 |
2.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
International |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Glaxo SmithKline |
10 |
1159 |
1812 |
1131.05 |
19634 |
169 |
2140 |
0 |
126.3 |
3230 |
445 |
26.3 |
44.1 |
9.2 |
75 |
Abbott India |
10 |
8646.05 |
8998.95 |
6900 |
18372 |
21 |
2009 |
0 |
945.2 |
3792 |
450 |
211.9 |
40.8 |
9.1 |
74.99 |
Pfizer |
10 |
3102 |
3840 |
2490 |
14191 |
46 |
3011 |
3 |
658.2 |
2249 |
429 |
93.8 |
33.1 |
4.7 |
63.92 |
AstraZeneca |
2 |
1839.7 |
2398.55 |
1306.8 |
4599 |
5 |
301 |
0 |
120.3 |
745 |
54 |
21.8 |
84.5 |
15.3 |
75 |
Procter and Gamble |
10 |
4510 |
4995 |
2172 |
7486 |
17 |
1564 |
0 |
942.4 |
919 |
857 |
516.1 |
8.7 |
4.8 |
51.82 |
Company & JSAlphaa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|